Cargando…

Dengue seroprevalence: data from the clinical development of a tetravalent dengue vaccine in 14 countries (2005–2014)

Dengue seroprevalence data in the literature is limited and the available information is difficult to compare between studies because of the varying survey designs and methods used. We assessed dengue seropositivity across 14 countries using data from 15 trials conducted during the development of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	L’Azou, Maïna, Assoukpa, Jade, Fanouillere, Karen, Plennevaux, Eric, Bonaparte, Matthew, Bouckenooghe, Alain, Frago, Carina, Noriega, Fernando, Zambrano, Betzana, Ochiai, R Leon, Guy, Bruno, Jackson, Nicholas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972646/ https://www.ncbi.nlm.nih.gov/pubmed/29800279 http://dx.doi.org/10.1093/trstmh/try037

Ejemplares similares

Impact of Dengue Vaccination on Serological Diagnosis: Insights From Phase III Dengue Vaccine Efficacy Trials
por: Plennevaux, Eric, et al.
Publicado: (2018)

Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico
por: Dayan, Gustavo H, et al.
Publicado: (2014)

Analysis of Hospitalized and Severe Dengue Cases Over the 6 years of Follow-up of the Tetravalent Dengue Vaccine (CYD-TDV) Efficacy Trials in Asia and Latin America
por: Forrat, Rémi, et al.
Publicado: (2021)

Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination
por: Vigne, Claire, et al.
Publicado: (2017)

Genetic epidemiology of dengue viruses in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacy
por: Rabaa, Maia A, et al.
Publicado: (2017)

Symptomatic Dengue Disease in Five Southeast Asian Countries: Epidemiological Evidence from a Dengue Vaccine Trial
por: Nealon, Joshua, et al.
Publicado: (2016)

Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2–16 Years in Asia and Latin America
por: Olivera-Botello, Gustavo, et al.
Publicado: (2016)

Secondary Analysis of the Efficacy and Safety Trial Data of the Tetravalent Dengue Vaccine in Children and Adolescents in Colombia
por: Reynales, Humberto, et al.
Publicado: (2020)

Dengue Seroprevalence in the French West Indies: A Prospective Study in Adult Blood Donors
por: L'Azou, Maïna, et al.
Publicado: (2015)

Resource Use and Costs of Dengue: Analysis of Data from Phase III Efficacy Studies of a Tetravalent Dengue Vaccine
por: El Fezzazi, Hanna, et al.
Publicado: (2017)

Epidemiological Trends of Dengue Disease in Thailand (2000–2011): A Systematic Literature Review
por: Limkittikul, Kriengsak, et al.
Publicado: (2014)

CYD Tetravalent Dengue Vaccine Performance by Baseline Immune Profile (Monotypic/Multitypic) in Dengue-Seropositive Individuals
por: DiazGranados, Carlos A, et al.
Publicado: (2020)

Epidemiology of Dengue Disease in Malaysia (2000–2012): A Systematic Literature Review
por: Mohd-Zaki, Abdul Hamid, et al.
Publicado: (2014)

Reviewing the Literature for Epidemiological Trends of Dengue Disease: Introduction to a Series of Seven National Systematic Literature Reviews
por: L'Azou, Maïna, et al.
Publicado: (2014)

Epidemiology of Dengue Disease in the Philippines (2000–2011): A Systematic Literature Review
por: Bravo, Lulu, et al.
Publicado: (2014)

Recent Epidemiological Trends of Dengue in the French Territories of the Americas (2000–2012): A Systematic Literature Review
por: L'Azou, Maïna, et al.
Publicado: (2014)

Immunogenicity of the CYD tetravalent dengue vaccine using an accelerated schedule: randomised phase II study in US adults
por: Kirstein, Judith, et al.
Publicado: (2018)

Humoral and cellular immunogenicity and safety following a booster dose of a tetravalent dengue vaccine 5+ years after completion of the primary series in Singapore: 2-year follow-up of a randomized phase II, placebo-controlled trial
por: Park, Juliana, et al.
Publicado: (2021)

Zika and Dengue Interactions in the Context of a Large Dengue Vaccine Clinical Trial in Latin America
por: Zambrano, Betzana, et al.
Publicado: (2021)

Associations of human leukocyte antigen with neutralizing antibody titers in a tetravalent dengue vaccine phase 2 efficacy trial in Thailand
por: Thomas, Rasmi, et al.
Publicado: (2022)

Dengue: etiology of acute febrile illness in Abidjan, Côte d'Ivoire, in 2011–2012
por: L'Azou, Maïna, et al.
Publicado: (2015)

Effect of the Tetravalent Dengue Vaccine TAK-003 on Sequential Episodes of Symptomatic Dengue
por: Sáez-Llorens, Xavier, et al.
Publicado: (2023)

Dengue Endemicity, Force of Infection, and Variation in Transmission Intensity in 13 Endemic Countries
por: Nealon, Joshua, et al.
Publicado: (2020)

Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City
por: Biswal, Shibadas, et al.
Publicado: (2021)

Corrigendum to: Dengue Endemicity, Force of Infection and Variation in Transmission Intensity From 13 Endemic Countries
por: Nealon, Joshua, et al.
Publicado: (2020)

Economic Impact of Dengue Illness in the Americas
por: Shepard, Donald S., et al.
Publicado: (2011)

A tetravalent dengue nanoparticle stimulates antibody production in mice
por: Silva, Elisângela F, et al.
Publicado: (2012)

Current Development and Challenges of Tetravalent Live-Attenuated Dengue Vaccines
por: Hou, Jue, et al.
Publicado: (2022)

Costs of dengue in three French territories of the Americas: an analysis of the hospital medical information system (PMSI) database
por: Uhart, M., et al.
Publicado: (2015)

Immunogenicity and safety of a tetravalent dengue vaccine in healthy adults in India: A randomized, observer-blind, placebo-controlled phase II trial
por: Dubey, Anand Prakash, et al.
Publicado: (2015)

Laboratory-confirmed Dengue in Children in Three Regional Hospitals in the Philippines in 2009−2010
por: Capeding, Maria Rosario Z., et al.
Publicado: (2015)

Simulations to compare efficacies of tetravalent dengue vaccines and mosquito vector control
por: THAVARA, U., et al.
Publicado: (2014)

Challenges to the Design of Clinical Trials for Live-Attenuated Tetravalent Dengue Vaccines
por: Russell, Philip K., et al.
Publicado: (2016)

Design of Monovalent and Chimeric Tetravalent Dengue Vaccine Using an Immunoinformatics Approach
por: Dixit, Neeraj Kumar
Publicado: (2021)

Efficacy of Tetravalent Dengue Vaccine: A Systematic Review and Meta-Analysis
por: Khobragade, Ashish Wasudeo, et al.
Publicado: (2021)

Development of MVA-d34 Tetravalent Dengue Vaccine: Design and Immunogenicity
por: Mintaev, Ramil R., et al.
Publicado: (2023)

Immunogenicity and Safety of a Recombinant Tetravalent Dengue Vaccine in Children and Adolescents Ages 9–16 Years in Brazil
por: Dayan, Gustavo H., et al.
Publicado: (2013)

Seroprevalence of Dengue and Chikungunya Virus Antibodies, French Polynesia, 2014–2015
por: Aubry, Maite, et al.
Publicado: (2018)

Induction of Neutralizing Antibodies against Four Serotypes of Dengue Viruses by MixBiEDIII, a Tetravalent Dengue Vaccine
por: Zhao, Hui, et al.
Publicado: (2014)

Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials
por: Tran, Ngoc Huu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ffajmeoporl4c3rifrthji2etq